The Chemours Company CC
$14.58
-$0.45-2.99%
NYSE
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | -1.49% | 0.95% | -2.13% | -0.86% | 3.93% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -1.49% | 0.95% | -2.13% | -0.86% | 3.93% |
| Cost of Revenue | -2.39% | 3.27% | 7.04% | 3.11% | 7.30% |
| Gross Profit | 2.88% | -10.17% | -40.00% | -17.83% | -9.74% |
| SG&A Expenses | 86.82% | 19.83% | -45.88% | -22.22% | -15.13% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 5.29% | 4.69% | -0.84% | 0.36% | 4.92% |
| Operating Income | -85.12% | -53.41% | -40.00% | -14.75% | -6.92% |
| Income Before Tax | 99.60% | -- | -- | 259.38% | -459.42% |
| Income Tax Expenses | 108.40% | 40.00% | -141.67% | -- | 1,355.56% |
| Earnings from Continuing Operations | 27.70% | -480.00% | -416.67% | 287.50% | -731.67% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 27.89% | -480.00% | -408.33% | 287.50% | -733.33% |
| EBIT | -85.12% | -53.41% | -40.00% | -14.75% | -6.92% |
| EBITDA | -53.99% | -31.82% | 10.08% | -6.15% | 4.41% |
| EPS Basic | 28.36% | -475.75% | -406.12% | 286.67% | -729.81% |
| Normalized Basic EPS | -159.87% | -100.00% | -123.29% | -27.84% | -15.21% |
| EPS Diluted | 28.38% | -475.75% | -412.48% | 281.41% | -748.72% |
| Normalized Diluted EPS | -159.87% | -100.00% | -123.29% | -28.05% | -14.81% |
| Average Basic Shares Outstanding | 0.66% | 0.57% | 0.43% | 0.42% | 0.55% |
| Average Diluted Shares Outstanding | 0.66% | 0.57% | 0.43% | 0.72% | 0.08% |
| Dividend Per Share | 0.00% | -65.00% | -65.00% | -65.00% | -65.00% |
| Payout Ratio | -0.39% | 0.94% | 0.92% | 1.18% | -1.06% |